|[May 01, 2014]
Fitch Rates LifePoint's Proposed Senior Notes 'BB'
NEW YORK --(Business Wire)--
Fitch Ratings has assigned a 'BB' rating to LifePoint Hospitals, Inc.'s
(LifePoint) $400 million proposed senior unsecured notes. Proceeds of
the notes will be used to partially retire the company's $575 million
convertible subordinated notes maturing later this month. A complete
list of ratings follows at the end of this release. The ratings apply to
approximately $2.4 billion of debt at March 31, 2014. The Rating Outlook
KEY RATING DRIVERS
--Pro forma for the $400 million notes issue and pay-down of the
convertible subordinated notes maturity, LifePoint's pro forma leverage
(total debt to EBITDA) of 4.0x EBITDA, is amongst the lowest in the
for-profit hospital industry.
--Debt has recently trended higher as the result of funding of
acquisitions and share repurchases, and Fitch expects the company to
continue to deploy capital for these purposes in 2014.
--Liquidity is solid. Lower profitability resulting from the integration
of recently acquired hospitals is expected to pressure the level of free
cash flow (FCF; cash from operations less dividends and capital
expenditures), but Fitch expects it to remain above $150 million
--Organic growth in patient volume has been persistently weak across the
for-profit hospital industry. However, LifePoint's recent hospital
acquisitions in relatively faster growing markets will support growth
for the company.
MORE AGGRESSIVE CAPITAL DEPLOYMENT DRIVING HIGHER LEVERAGE
At 4.2x total debt to EBITDA at March 31, 2013, LifePoint Hospital
Inc.'s (LifePoint) leverage is amongst the lowest in the for-profit
hospital industry, commensurate with the strong financial flexibility
required for a 'BB' category rating. However, leverage is up
substantially over the past year, and Fitch expects it to be maintained
near 4.0x after pay-down of the $575 million convertible subordinated
Unless risk associated with higher leverage is offset by continued
decent operating results and FCF generation, it will result in a
downgrade of the ratings. Pro forma for the notes issuance and pay-down
of the senior subordinated convertible notes, Fitch estimates gross debt
leverage of 1.1x through the senior secured bank debt and 3.9x through
the senior unsecured notes.
In addition to the upcoming notes maturity, the primary uses of cash in
the first half of 2014 include several hospital acquisitions and share
repurchases. Acquisitions have been a top use of cash for LifePoint,
consuming 52% of cash from operations in 2012 and 2013 and 34% in the
LTM ended March 31, 2014. The company closed one transaction so far
2014, requiring a $60 million cash commitment, and has announced several
transactions expected to close later in the year.
In recent transactions, LifePoint has added inpatient acute care
hospital assets in relatively faster growing markets, including markets
in three new states - North Carolina, Michigan and Indiana. Fitch thinks
this strategy achieves some important aims for LifePoint, including
boosting relatively weak organic growth in the company's existing
markets and reducing geographic concentration; 54% of 2013 revenue was
generated in the company's five largest states.
With CFO trending around $350 million and run-rate FCF of around $170
million, based on the cost of its past acquisitions, Fitch estimates
that LifePoint can fund two or three transactions with cash on hand
annually. However, given the rapid pace of transactions and the recently
larger cash commitments associated with some acquisitions, there is a
risk that funding of the acquisition strategy could result in leverage
sustained above the 4.0x level that is consistent with the 'BB' rating.
DECENT FINANCIAL FLEXIBILITY
At March 31, 2014, liquidity was provided by approximately $532 million
of cash on hand, availability on the company's $350 million bank credit
facility revolver ($330 million available), and FCF ($201 million for
the latest 12 months [LTM] period, defined as cash from operations less
dividends and capital expenditures).
The largest upcoming maturity is the $575 million senior subordinated
convertible notes maturing May 2014. Fitch expects the company will pay
down the maturity using cash on hand, including proceeds of the $400
million proposed notes. Subsequent to the convertible notes maturity,
the next largest maturity does not occur until 2017. Fitch notes that
LifePoint has ample capacity to issue additional debt on either of the
secured or unsecured level. The bank agreement permits additional
secured debt up to a senior secured leverage ratio of 3.5x with an $800
million carveout regardless of the ratio (there is a springing lien
provision in the senior unsecured notes indenture which required these
notes to become ratably secured when secured debt is greater than 3.0x
EBITDA). A financial maintenance covenant requires total-debt-to-EBITDA
maintained below 5.0x.
Fitch projects that LifePoint's FCF will contract by about $40 million
in 2014 versus the March 31, 2014 LTM level of $201 million, to $160
million. This is because of lower profitability and higher capital
expenditures later in the year. An expectation for a slight contraction
in the EBITDA margin is primarily because of the integration of less
profitable acquired hospitals.
RURAL MARKET RECOVERY LAGGING BROADER INDUSTRY
LifePoint is the only pure-play non-urban operator in the for-profit
hospital industry, with a sole-provider position in nearly all of its 60
markets, although the company has gained exposure in larger rural and
small suburban markets through some of its recent acquisitions. Having
sole-provider status in the vast majority of markets confers certain
benefits on LifePoint in capturing organic patient volume growth as well
as in negotiating price increases with commercial health insurers.
While LifePoint's organic patient volume growth has recently lagged the
broader for-profit hospital industry, the company's results have been
consistent with the experience of other rural and suburban market
hospital operators. While persistently weak organic volume trends across
the industry began to show signs of improvement in the second half of
2011, providers in urban markets exhibited a much stronger rebound in
volume growth that has since reversed for most companies, with weak
organic volume trends industry-wide in 2012 - 2013.
LifePoint and the company's peers have recently been successful in
augmenting weak organic operating trends through acquisition of
inpatient hospitals and other types of care delivery assets.
Consolidation of the industry has been encouraged by the financial
pressures on smaller operators related to payment reforms that are
required by the Affordable Care Act (ACA), and capital requirements
necessary to comply with other government mandates, such as the
implementation of electronic health records.
AFFORDABLE CARE ACT A POSITIVE DRIVER IN 2014
LifePoint's Q1'14 operating results benefited from the early
implementation of the health insurance expansion provisions of the ACA,
including the mandate for individuals to purchase health insurance or
face a financial penalty, and the expansion of Medicaid eligibility.
Most of the benefit to LifePoint's results seems to have stemmed from a
reduction in self-pay volumes as opposed to higher utilization of
healthcare by newly insured individuals. This result is consistent with
Fitch expectations of the influence of the ACA on the hospital industry.
Expansion of state Medicaid program is of particular importance to
reduction in self-pay patients and the associated headwind of bad debt
expense for hospital companies. Seven of the 20 states in which
LifePoint operates hospitals expanded Medicaid programs on Jan. 1, 2014,
including five of the eight states where the company has its largest
revenue exposure. LifePoint estimates that about 80% of the uninsured
population of the seven states opting in to Medicaid expansion qualifies
for coverage under the new, more generous, income limitations. The
company further reports that 35% of self-pay patient volumes are
attributable to those same seven states.
A downgrade of the ratings could result from gross debt to EBITDA being
maintained above 4.0x and FCF generation sustained below $150 million
annually. The most likely driver of a negative rating action is debt
funding of capital deployment, including acquisitions and share
repurchases, contributing to leverage above 4.0x. In addition,
difficultly in the integration of recent acquisitions and the timing and
level of funding of capital projects in new markets could weigh on FCF
and the credit profile.
An upgrade of the ratings is not expected in the next several years. It
would require the company to commit to maintain leverage below 3.0x.
Fitch does not believe LifePoint has a financial incentive to operate
with leverage at such a low level, and it is inconsistent with the
company's recently more aggressive stance toward capital deployment.
DEBT ISSUE RATINGS
Fitch currently rates LifePoint as follows:
--Issuer Default Rating 'BB';
--Secured bank facility 'BB+';
--Senior unsecured notes 'BB';
--Subordinated convertible notes 'BB-'.
Additional information is available at 'www.fitchratings.com'.
Applicable Criteria and Related Research:
--'Hospitals Credit Diagnosis' (April 10, 2014);
--'High-Yield Healthcare Checkup' (April 4, 2014);
--'2014 Outlook: U.S. Healthcare' (Nov. 25, 2013).
--'For Profit Hospital Insights: Fitch's Annual Review of Bad Debt
Accounting Policies and Practices' (Oct. 24, 2013);
--'Margin Preservation Strategies: Different Angles (U.S. Hospitals and
Health Insurers)' (Oct. 1, 2013);
--'The Affordable Care Act and Healthcare Providers: Assessing the
Potential Impact' (May 1, 2013);
--'Corporate Rating Methodology' (Aug. 5, 2013).
Applicable Criteria and Related Research:
Hospitals Credit Diagnosis (Consolidation Supports Growth in a Weak
Organic Operating Environment)
High-Yield Healthcare Checkup: Comprehensive Analysis of High-Yield U.S.
2014 Outlook: U.S. Healthcare -- Secular Challenges Require a Compelling
For Profit Hospital Insights: Changes in Bad Debt Reporting Will Improve
Margin Preservation Strategies -- Different Angles (Credit Implications
for U.S. Hospitals and Health Insurers)
The Affordable Care Act and Healthcare Providers (Assessing the
Corporate Rating Methodology -- Effective 12 August 2011 to 8 August 2012
ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND
DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING
THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS.
AVAILABLE ON (News - Alert) THE AGENCY'S PUBLIC WEBSITE 'WWW.FITCHRATINGS.COM'.
PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS
SITE AT ALL TIMES. FITCH'S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS
OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES
AND PROCEDURES ARE ALSO AVAILABLE FROM THE 'CODE OF CONDUCT' SECTION OF
THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE
RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR
RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY
CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH
[ InfoTech Spotlight's Homepage ]